STAT1 gene
The STAT1 gene provides instructions for a protein that regulates immune system pathways, balancing defense against infections with the control of inflammatory responses.
Normal Function
The STAT1 gene provides instructions for making a protein that is involved in multiple immune system functions, including the body's defense against a fungus called Candida. When the immune system recognizes Candida, it generates cells called Th17 cells. These cells produce signaling molecules (cytokines) called the interleukin-17 (IL-17) family as part of an immune process called the IL-17 pathway. The IL-17 pathway sends other cytokines and white blood cells to fight foreign invaders and promote tissue repair. The STAT1 protein helps keep the immune system in balance by blocking (inhibiting) this pathway when activated.
In contrast to its inhibitory role in the IL-17 pathway, the STAT1 protein helps promote other immune processes called the interferon-alpha/beta (IFNA/B) and interferon-gamma (IFNG) signaling pathways. The IFNA/B pathway is important in defense against viruses, and the IFNG pathway helps fight a type of bacteria called mycobacteria, which includes the bacterium that causes tuberculosis.
Health Conditions Related to Genetic Changes
Familial candidiasis
At least 35 STAT1 gene mutations have been identified in people with familial candidiasis, an inherited tendency to develop chronic infections of the skin, nails, and mucous membranes caused by the Candida fungus. These mutations are described as "gain of function" because they increase the amount of activated STAT1 protein in cells. By increasing STAT1's inhibitory effect on the IL-17 pathway, the mutations impair the body's ability to fight Candida.
Other disorders
STAT1 gene mutations can also cause other immune system problems known as immunodeficiency 31A and immunodeficiency 31B. These are described as "loss-of-function" mutations because they impair or eliminate the protein's normal action:
- Immunodeficiency 31A: Impairs the STAT1 protein's function in the IFNG pathway, resulting in an increased susceptibility to mycobacteria.
- Immunodeficiency 31B: A more severe disorder that impairs both the IFNG and IFNA/B pathways, resulting in susceptibility to both viral infections (such as herpes simplex and viral encephalitis) and mycobacterial infections.
Other Names for This Gene
- IMD31A
- IMD31B
- IMD31C
- ISGF-3
- signal transducer and activator of transcription 1, 91kDa
- signal transducer and activator of transcription-1
- STAT91
- transcription factor ISGF-3 components p91/p84
